GSK, CureVac to make COVID-19 vaccines aimed at new variants

Posted on by Leave a comment


U.K.-based drugmaker GlaxoSmithKline and Germany’s CureVac say they plan to collaborate to develop new vaccines that can target emerging variants of COVID-19…

Source

tagged with , , , ,

Leave a Reply